Adding a single cycle of rituximab to belimumab (Benlysta) did not improve disease control for patients with systemic lupus erythematosus (SLE) in comparison with belimumab alone in a phase 3 ...

In a new study, rituximab therapy was found to be an effective treatment option for lupus nephritis (LN) management. After six months of use, people with lupus nephritis taking the therapy showed ...

ATLANTA—Lupus nephritis patients who receive rituximab earlier in the course of their disease rather than later have better outcomes, new findings suggest. “We have been trying to use rituximab in a ...

Please provide your email address to receive an email when new articles are posted on . Rheumatologists opt for therapy regimens that include rituximab more often than nephrologists in treating ...

Please provide your email address to receive an email when new articles are posted on . Belimumab after rituximab reduces serum IgG anti-double-stranded DNA antibody levels and the risk for severe ...

Prescription bottle Researchers evaluated the safety, mechanism of action, and preliminary efficacy of rituximab and cyclophosphamide followed by belimumab in the treatment of refractory lupus ...

Full peer-reviewed results from the closely watched BEAT-LUPUS trial have now been published, confirming that systemic lupus erythematosus (SLE) patients can benefit from a one-two biologic punch. SLE ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding a cycle ...

Adverse effects of induction therapies for lupus nephritis may limit their use. Among the 4 induction therapies for lupus nephritis (LN), rituximab carries the highest probability of infection and ...

SAN DIEGO--(BUSINESS WIRE)--Artiva Biotherapeutics, Inc., a clinical stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-based therapies, ...